Alpha Tau to Participate at Jefferies Global Healthcare Conference in London

Rhea-AI Summary

Alpha Tau (NASDAQ: DRTS) said CFO Raphi Levy will participate at the Jefferies Global Healthcare Conference in London on November 18–19, 2025.

Mr. Levy will take part in 1x1 investor meetings; investors should contact their Jefferies representative to schedule meetings.

News Market Reaction – DRTS

+0.51%

+0.51% Session close to close

In the Nov 11 session, DRTS gained 0.51%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

JERUSALEM, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT^®, today announced that CFO Raphi Levy will participate at the Jefferies Global Healthcare Conference in London on November 18-19, 2025.

Event:	Jefferies Global Healthcare Conference
Format:	1X1 Investor meetings
Date:	November 18-19, 2025
Location:	London

Mr. Levy will be available for 1x1 investor meetings. Please reach out to your Jefferies representative to schedule.

About Alpha Tau Medical Ltd.

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.

About Alpha DaRT^®

Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is designed to enable highly potent and conformal alpha-irradiation of solid tumors by intratumoral delivery of radium-224 impregnated sources. When the radium decays, its short-lived daughters are released from the sources and disperse while emitting high-energy alpha particles with the goal of destroying the tumor. Since the alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims to mainly affect the tumor, and to spare the healthy tissue around it.

Investor Relations Contact:

IR@alphatau.com

FAQ

When will Alpha Tau (DRTS) participate at the Jefferies Global Healthcare Conference in London?

Alpha Tau (NASDAQ: DRTS) will participate on November 18–19, 2025.

Who from Alpha Tau will attend the Jefferies Global Healthcare Conference on November 18–19, 2025?

CFO Raphi Levy will represent Alpha Tau and be available for investor meetings.

What format will Alpha Tau use for investor engagement at the Jefferies conference (DRTS)?

Alpha Tau will conduct 1x1 investor meetings during the conference.

How can investors schedule a meeting with Alpha Tau (DRTS) at the Jefferies Global Healthcare Conference?

Investors should contact their Jefferies representative to arrange 1x1 meetings with Alpha Tau.

Where is the Jefferies Global Healthcare Conference taking place for Alpha Tau (DRTS)?

The conference is in London on November 18–19, 2025.

Will Alpha Tau (DRTS) present a public webcast or only hold 1x1 meetings at the Jefferies conference?

The announcement specifies 1x1 investor meetings; no public webcast or presentation was mentioned.